Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody

Journal of the Neurological Sciences

Volumn 168, Issue 1, 1999, Pages 28-31

  Tanaka, Masami ^a   Tanaka, Keiko ^b   Tokiguchi, Susumu ^c   Shinozawa, Kazuki ^d   Tsuji, Shoji ^b  

^a Natl W Niigata Ctrl H ^*  (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Department of Neurology   (Japan)

^d Saiseikai Kawaguchi General Hospital   (Japan)

Author keywords

Anti Yo antibody; Cerebellar ataxia; Cytotoxic T cells; Paraneoplastic syndrome; Reverse immunogenetics

Indexed keywords

LEUCINE ZIPPER PROTEIN;

ARTICLE; ATAXIA; CEREBELLUM DEGENERATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENETICS; MONONUCLEAR CELL; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL;

AUTOANTIBODIES; AUTOANTIGENS; DNA-BINDING PROTEINS; EPITOPES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; PEPTIDE FRAGMENTS; PURKINJE CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032870539     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00163-X     Document Type: Article

References (14)

1. Posner J.B. Paraneoplastic syndromes. Neurologic complications of cancer. 1995;353-385 F.A. Davis Company, Philadelphia.
2. Jaeckle K.A., Stroop W.G., Greenlee J.E., Price M., Deng Q.S. Intraventricular injection of paraneoplastic anti-Purkinje cell antibody in a rat model. Neurology. 6:1986;332.
3. Tanaka M., Tanaka K., Onodera O., Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin Neurol Neurosurg. 97:1995;95-100.
4. Tanaka M., Tanaka K. HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody. Neurology. 47:1996;606-607.
5. Rammensee H.-G., Friede T., Stevanovic S. MHC ligands and peptide motifs; first listing. Immunogenet. 41:1995;178-228.
6. Tanaka K., Tanaka M., Igarashi S., Onodera O., Miyatake T., Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci. 127:1994;153-158.
7. Kubo R.T., Sette A., Grey N.M., et al. Definition of specific peptide motifs for four major HLA-A alleles. J Immunol. 1994;3913-3924.
8. Giometto B., Marchiori G.C., Nicolao P., et al. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol. 23:1997;468-474.
9. Haridas V., Saxena R.K. Changes in LAK susceptibility of tumor cells as their MHC class I antigen expression levels regenerate after treatment at pH 3.0. Immunol Lett. 44:1995;7-11.
10. Rensing-Ehl A., Malipiero U., Irmler M., Tschopp J., Constam D., Fontana A. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur J Immunol. 26:1996;2271-2274.
11. Tanaka M., Tanaka K., Shinozawa K., Idezuka K., Tsuji S. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci. 161:1998;88-90.
12. Yang Y., Wilson J.M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol. 155:1995;2564-2570.
13. Davenport M.P., Hill A.V.S. Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol Med Today. 2:1996;38-45.
14. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Med. 4:1998;1321-1324.